Reply to letter in response to Rethinking the diagnosis of double-seronegative myasthenia gravis

Eur J Neurol. 2024 Mar;31(3):e16152. doi: 10.1111/ene.16152. Epub 2023 Nov 22.

Authors

Rodrigo Martinez-Harms^{1

2}, Carolina Barnett^{1

2}, Monica Alcantara^{1

2}, Vera Bril^{1

2}

Affiliations

¹ Ellen & Martin Prosserman Centre for Neuromuscular Diseases, Toronto General Hospital, Toronto, Ontario, Canada.
² University Health Network, University of Toronto, Toronto, Ontario, Canada.

PMID: 37991152
DOI: 10.1111/ene.16152

No abstract available

Publication types

Letter

MeSH terms

Humans
Myasthenia Gravis* / diagnosis
Receptors, Cholinergic

Substances

Receptors, Cholinergic